Cancer: A Journey Through History and Modern Treatment Approaches

Cancer is a complex and multifaceted disease, characterized by uncontrolled cell growth that disrupts the delicate balance between cell proliferation and cell death. This loss of regulation leads to the development of abnormal cell populations that can spread to other tissues, a process known as metastasis. Cancer has been a part of human history for millennia, with some of the earliest records found in the Egyptian Edwin Smith Papyrus dating back to around 1600 B.C. Despite its ancient origins, cancer remains one of the most significant challenges to modern medicine.

Types of Cancer
There are many types of cancer, classified by the location of the primary tumor or the type of cell where the cancer originates. For example, lung, breast, prostate, and bone cancers are named for the tissues they affect. Cancer can also be categorized by the type of cell involved, such as carcinoma, sarcoma, leukemia, lymphoma, multiple myeloma, and melanoma.

Carcinoma is the most common type of cancer, originating from epithelial cells.
Sarcoma forms in tissues like bone, muscle, and fat.
Leukemia affects the blood-forming tissues, particularly the bone marrow.
Lymphoma involves cancer in lymphocytes, while multiple myeloma affects plasma cells.
Melanoma develops from melanocytes, the cells that produce pigment in the skin.

Causes of Cancer
Several environmental, behavioral, and genetic factors contribute to cancer development. Lifestyle factors such as alcohol consumption, tobacco use, chronic inflammation, radiation exposure, and sun exposure are known risk factors. Additionally, diet and other behaviors can influence cancer risk. On the genetic side, mutations in critical genes can predispose individuals to cancer. For example, mutations in the TP53 gene can disrupt the production of tumor-suppressing proteins, while mutations in BRCA1 and BRCA2 significantly increase the risk of breast and ovarian cancers.

Osteosarcoma: A Common Bone Cancer
Among the various types of bone cancer, osteosarcoma is the most common. It primarily affects teenagers and older adults. Osteosarcoma cells rapidly divide and form new bone tissue, most commonly in the long bones of the legs. This cancer can be further classified into different types:
Osteoblastic osteosarcoma involves bone-forming cells.
Chondroblastic osteosarcoma originates from cartilage-forming cells.
Fibroblastic osteosarcoma involves cancerous spindle cells.

Treatment Methods for Cancer
Over the years, cancer treatment has evolved significantly, with the aim of improving patient outcomes and quality of life. The main treatment modalities include surgery, chemotherapy, radiotherapy, immunotherapy, viral therapy, and targeted therapy.

1. Surgerys
Surgery is often the first line of treatment for cancer, involving the physical removal of cancerous tissue. The success of surgery depends on the accurate localization of the tumor, often aided by imaging techniques such as CT scans, PET scans, and MRI scans. However, surgery alone may not be enough to eliminate all cancer cells.

2. Chemotherapy
Chemotherapy is used to destroy any remaining cancer cells after surgery and to prevent metastasis. While it can be effective, cancer cells' genomic instability can lead to drug resistance, making treatment more challenging.

3. Radiotherapy
Radiotherapy is used in approximately half of all cancer patients. It works by damaging the DNA of cancer cells, ultimately leading to their death. However, radiotherapy can also harm healthy cells, causing various side effects.

4. Immunotherapy
Immunotherapy harnesses the power of the immune system to fight cancer. Since cancer originates from a person’s own cells, the immune system may not always recognize it as a threat. Immunotherapy techniques such as monoclonal antibodies, immune checkpoint inhibitors, and cancer vaccines have been developed to help the immune system target and destroy cancer cells more effectively.

Monoclonal antibodies are designed to bind specifically to cancer cells, marking them for destruction by the immune system.

5. Viral Therapy
In viral therapy, certain viruses—called oncolytic viruses—are used to selectively infect and kill cancer cells. These viruses can occur naturally or be genetically engineered. The first FDA-approved oncolytic virus drug, T-Vec, is a modified herpes simplex virus that replicates within and destroys cancer cells.

6. Targeted Therapy
Targeted therapy is a specialized form of chemotherapy that focuses on specific molecular targets within cancer cells. For instance, human epidermal growth factor receptor 2 (HER2) is targeted in breast cancer treatments, while epidermal growth factor receptor (EGFR) is targeted in lung and colorectal cancers.

Conclusion
Cancer remains one of the most critical health challenges worldwide. Understanding the different types of cancer and their underlying causes is essential for developing effective treatments. As science continues to evolve, treatments like immunotherapy, targeted therapy, and viral therapy offer hope for more precise and effective cancer management. Ongoing research holds the promise of new breakthroughs that could one day bring us closer to curing this ancient disease.

References:
Ruddon, R. W. (2007). Cancer Biology. New York: Oxford university press. Hajdu, S. I. (2011). A note from history: landmarks in history of cancer, part 1. Cancer, 117(5), 1097-1102.
Berman, J. J., (2004). Tumor taxonomy for the developmental lineage classification of neoplasms. BMC Cancer, 4 (1), 88. doi:10.1186/1471-2407-4-88.
Surget, S., Khoury, M. P., Bourdon, J. C., (December 2013). Uncovering the role of p53 splice variants in human malignancy: a clinical perspective. OncoTargets and Therapy, 7, 57–68. doi:10.2147/OTT.S53876. PMC 3872270 Freely accessible. PMID 24379683.
Roukos D. H., (April 2009). Genome-wide association studies: how predictable is a person's cancer risk?. Expert Review of Anticancer Therap,. 9 (4): 389–92. doi:10.1586/era.09.12.
Ottaviani, G., Jaffe, N., (2009). The epidemiology of osteosarcoma. In: Jaffe N. et al. Pediatric and Adolescent Osteosarcoma. New York: Springer. doi:10.1007/978-1-4419-0284-9_1.
Neville, B. W., Damm, D. D., Allen, C. M., Bouquot, J. E., editors. Oral and Maxillofac Pathol. 2nd. Philadelphia: WB Saunders; 2002.
Epstein, R. J., (2005). Maintenance therapy to suppress micrometastasis: the new challenge for adjuvant cancer treatment. Clinical Cancer Research, 11 (15), 5337–41. doi:10.1158/1078-0432.
Vennepureddy, A., Singh, P., Rastogi, R., Atallah, J. P., Terjanian, T. (2016). Evolution of ramucirumab in the treatment of cancer - A review of literature. Journal of Oncology Pharmacy Practice. doi:10.1177/1078155216655474.
Ledford, H. (2015). Cancer-fighting viruses win approval. Nature, 526, 622-623.
Le, X. F., Pruefer, F., Bast, R. C., (2005). HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27Kip1 via multiple signaling pathways. Cell Cycle, 4 (1): 87–95. doi:10.4161/cc.4.1.1360.